awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34788381-135DCC9A-2CF7-4FE4-93A3-57F2E8415AFE
Q34788381-135DCC9A-2CF7-4FE4-93A3-57F2E8415AFE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-135DCC9A-2CF7-4FE4-93A3-57F2E8415AFE
Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
P2860
Q34788381-135DCC9A-2CF7-4FE4-93A3-57F2E8415AFE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-135DCC9A-2CF7-4FE4-93A3-57F2E8415AFE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be5785cf000da412af12f9d614db0992be06798d
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).